- 1 Overview of Actinium
- 2 Blockchain
- 3 Mine
- 4 Forgot your password?
- 5 Happily Ever After?
- 6 How Easily Can Actinium Pharmaceuticals Raise Cash?
- 7 How Is Actinium Pharmaceuticals' Cash Burn Changing Over Time?
- 8 Is Actinium Pharmaceuticals' Cash Burn A Worry?
- 9 What is Actinium?
- 10 When Might Actinium Pharmaceuticals Run Out Of Money?
- 11 History of Actinium
Overview of Actinium
radioactivity, Actinium glows in the dark with a pale blue light. it’s found only
in traces in uranium ores as 227Ac, an alpha and beta emitter with a half-life
of 21.773 years. One ton of uranium ore contains about a tenth of a gram of
the electronic shell structure is [2, 8, 18, 32, 18, 9, 2] with Atomic Term Symbol (Quantum Numbers) 2D3/2.
Additionally, Actinium is completely decentralized featuring an open-source codebase available for review, critique, and change from anyone.Designed to continuously incorporate innovative new features accordingly.The full breadth of the blockchain industry has yet to be realized which is why the development of Actinium remains perpetual and ever-expanding.The future of blockchain technology is bright and The Actinium Network strives to be equally radiant by ensuring its users have access to all the advantages this industry has to offer, both now and in the future.
Actinium is a cryptocurrency designed to be convenient, functional and secure.Featuring an active Lightning Network, Hardware Wallet integration, Tor Browser capabilities, as well as maintaining a heavy focus on education and every day application, Actinium aims to make blockchain technology useful for everyone.The Actinium Network is dedicated to sustaining a foundation of transparency and trust, which is why the project was launched fairly, meaning there is no pre-mine, no ICO, no pre-launch funding and no developer rewards of any sort associated with this project—whatsoever.
Forgot your password?
Enter your email address below.
Happily Ever After?
Having resolved many of the biggest issues, the Tri-Lab project team is in the midst of working out the new process’s details.They estimate they can provide more than 20 times as much actinium-225 to medical researchers as they were able to originally.Those researchers are now investigating what dosages would maximize effectiveness while minimizing the drug’s toxicity.At the same time, the national labs are pursuing upgrades to expand production to the level needed for a commercial drug.They’re also working to make the entire process more efficient.
How Easily Can Actinium Pharmaceuticals Raise Cash?
While its cash burn is only increasing slightly, Actinium Pharmaceuticals shareholders should still consider the potential need for further cash, down the track.Companies can raise capital through either debt or equity.Many companies end up issuing new shares to fund future growth.By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate).
How Is Actinium Pharmaceuticals' Cash Burn Changing Over Time?
Because Actinium Pharmaceuticals isn't currently generating revenue, we consider it an early-stage business.Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation.It seems likely that the business is content with its current spending, as the cash burn rate stayed steady over the last twelve months.While the past is always worth studying, it is the future that matters most of all.So you might want to take a peek at how much the company is expected to grow in the next few years.
Is Actinium Pharmaceuticals' Cash Burn A Worry?
As you can probably tell by now, we're not too worried about Actinium Pharmaceuticals' cash burn.For example, we think its cash runway suggests that the company is on a good path.Although its increasing cash burn does give us reason for pause, the other metrics we discussed in this article form a positive picture overall.Shareholders can take heart from the fact that analysts are forecasting it will reach breakeven.Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs.On another note, Actinium Pharmaceuticals has 2 warning signs (and 1 which shouldn't be ignored) we think you should know about.
What is Actinium?
Actinium is the first element of the actinide series.All 36 known isotopes of actinium are radioactive.Ac 227 and 228 are naturally occurring isotopes with the half-life of 21.77 years and 6.13 hours respectively.It is 150 times more radioactive than radium.It is hazardous to health.If ingested, it gets deposited into the liver and bones, damaging the cells due to radioactive decay.
When Might Actinium Pharmaceuticals Run Out Of Money?
A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn.When Actinium Pharmaceuticals last reported its balance sheet in December 2020, it had zero debt and cash worth US$64m.Looking at the last year, the company burnt through US$22m.So it had a cash runway of about 2.9 years from December 2020.Importantly, though, analysts think that Actinium Pharmaceuticals will reach cashflow breakeven before then.In that case, it may never reach the end of its cash runway.You can see how its cash balance has changed over time in the image below.